TG Therapeutics TGTX Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by TG Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: TG Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about TG Therapeutics's operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TG Therapeutics's operating lease right-of-use assets in other assets?
- TG Therapeutics (TGTX) reported operating lease right-of-use assets in other assets of $6.48M in Q1 2026.
- How has TG Therapeutics's operating lease right-of-use assets in other assets changed year-over-year?
- TG Therapeutics's operating lease right-of-use assets in other assets decreased by 6.4% year-over-year, from $6.93M to $6.48M.
- What is the long-term trend for TG Therapeutics's operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), TG Therapeutics's operating lease right-of-use assets in other assets has grown at a -7.6% compound annual growth rate (CAGR), from $9.31M to $6.28M.